{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:57:07Z","timestamp":1771300627368,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["WAGNER15A0"],"award-info":[{"award-number":["WAGNER15A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jcf.2018.12.005","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T13:55:17Z","timestamp":1547214917000},"page":"114-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Application of multiple event analysis as an alternative approach to studying pulmonary exacerbations as an outcome measure"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6369-2353","authenticated-orcid":false,"given":"Elizabeth","family":"Juarez-Colunga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith T.","family":"Zemanick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2745-0103","authenticated-orcid":false,"given":"Brandie","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2018.12.005_bb0005","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/153.4.345","article-title":"Predictive 5-year survivorship model of cystic fibrosis","volume":"153","author":"Liou","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jcf.2018.12.005_bb0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1378\/chest.121.1.64","article-title":"Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis","volume":"121","author":"Britto","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2018.12.005_bb0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ppul.21374","article-title":"Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis","volume":"46","author":"Sanders","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2018.12.005_bb0020","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jclinepi.2014.12.010","article-title":"A statistical model to predict one-year risk of death in patients with cystic fibrosis","volume":"68","author":"Aaron","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jcf.2018.12.005_bb0025","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/ppul.23765","article-title":"Poor recovery from cystic fibrosis pulmonary exacerbations is associated with poor long-term outcomes","volume":"52","author":"Sanders","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2018.12.005_bb0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/thoraxjnl-2014-206750","article-title":"Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis","volume":"71","author":"Heltshe","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2018.12.005_bb0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.rmed.2008.09.024","article-title":"Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis","volume":"103","author":"Amadori","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.jcf.2018.12.005_bb0040","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/rccm.200909-1421OC","article-title":"Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation","volume":"182","author":"Sanders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2018.12.005_bb0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ppul.21117","article-title":"Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis","volume":"45","author":"Sanders","year":"2010","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"10.1016\/j.jcf.2018.12.005_bb0050","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/thx.2011.161117","article-title":"Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis -- de Boer et al. -- Thorax","volume":"66","author":"de Boer","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2018.12.005_bb0055","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/thoraxjnl-2012-202342","article-title":"Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age","volume":"68","author":"Byrnes","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2018.12.005_bb0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1479972311433575","article-title":"Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis","volume":"9","author":"Sequeiros","year":"2012","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.jcf.2018.12.005_bb0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1378\/chest.11-0917","article-title":"Incidence and risk factors for pulmonary exacerbation treatment failures in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa","volume":"141","author":"Parkins","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2018.12.005_bb0070","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1164\/rccm.200609-1354OC","article-title":"Association between pulmonary function and sputum biomarkers in cystic fibrosis","volume":"175","author":"Mayer-Hamblett","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2018.12.005_bb0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ppul.22767","article-title":"Effects of puberty on cystic fibrosis related pulmonary exacerbations in women versus men","volume":"49","author":"Sutton","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2018.12.005_bb0080","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jcf.2015.01.007","article-title":"Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients","volume":"14","author":"Waters","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2018.12.005_bb0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1191\/0962280202sm278ra","article-title":"Analysis of repeated events","volume":"11","author":"Cook","year":"2002","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jcf.2018.12.005_bb0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1164\/rccm.200807-1067OC","article-title":"Temporal clustering of exacerbations in chronic obstructive pulmonary disease","volume":"179","author":"Hurst","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2018.12.005_bb0095","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/ppul.22741","article-title":"A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care","volume":"48","author":"Sawicki","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2018.12.005_bb0100","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jcf.2015.10.006","article-title":"IV-treated pulmonary exacerbations in the prior year: an important independent risk factor for future pulmonary exacerbation in cystic fibrosis","author":"Vandevanter","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2018.12.005_bb0105","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1198\/016214507000000482","article-title":"Analysis of episodic data with application to recurrent pulmonary exacerbations in cystic fibrosis patients","volume":"103","author":"Yan","year":"2008","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jcf.2018.12.005_bb0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10985-010-9160-2","article-title":"Additive-multiplicative rates model for recurrent events","volume":"16","author":"Liu","year":"2010","journal-title":"Lifetime Data Anal"},{"key":"10.1016\/j.jcf.2018.12.005_bb0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1467-9868.2004.00442.x","article-title":"Recurrent events analysis in the presence of time-dependent covariates and dependent censoring","volume":"66","author":"Miloslavsky","year":"2003","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.jcf.2018.12.005_bb0120","series-title":"The statistical analysis of recurrent events","author":"Cook","year":"2007"},{"key":"10.1016\/j.jcf.2018.12.005_bb0125","series-title":"Hakon. Survival and event history Analysis","author":"Aalen","year":"2008"},{"key":"10.1016\/j.jcf.2018.12.005_bb0130","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.117.033065","article-title":"Comparison of Time-to-first event and Recurrent-Event Methods in Randomized Clinical Trials","author":"Claggett","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jcf.2018.12.005_bb0135","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00392-018-1205-7","article-title":"Time-to-first-event versus recurrent-event analysis: points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpoints","volume":"107","author":"Rauch","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jcf.2018.12.005_bb0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cct.2009.01.003","article-title":"Early anti-pseudomonal acquisition in young patients with cystic fibrosis: Rationale and design of the EPIC clinical trial and observational study^","volume":"30","author":"Treggiari","year":"2009","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jcf.2018.12.005_bb0145","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ppul.21279","article-title":"Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort","volume":"45","author":"Rosenfeld","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2018.12.005_bb0150","series-title":"Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry","year":"2015"},{"key":"10.1016\/j.jcf.2018.12.005_bb0155","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/cid\/cix203","article-title":"Cystic Fibrosis Pulmonary Exacerbations Attributable to respiratory Syncytial Virus and Influenza: a Population-based Study","volume":"64","author":"Somayaji","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2018.12.005_bb0160","series-title":"R: A language and environment for statistical computing","author":"R Development Core Team","year":"2008"},{"key":"10.1016\/j.jcf.2018.12.005_bb0165","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/biostatistics\/kxt054","article-title":"Efficient panel designs for longitudinal recurrent event studies recording panel counts","volume":"15","author":"Juarez-Colunga","year":"2014","journal-title":"Biostatistics (Oxford, England)"},{"key":"10.1016\/j.jcf.2018.12.005_bb0170","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jcf.2012.04.003","article-title":"Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort","volume":"11","author":"Rosenfeld","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2018.12.005_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0962280212445800","article-title":"Introduction to the special issue on joint modelling techniques","volume":"23","author":"Rizopoulos","year":"2014","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jcf.2018.12.005_bb0180","first-page":"809","article-title":"Joint modeling of longitudinal and time-to-event data: an overview","volume":"14","author":"Tsiatis","year":"2004","journal-title":"Stat Sinica"},{"key":"10.1016\/j.jcf.2018.12.005_bb0185","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/biostatistics\/1.4.465","article-title":"Joint modelling of longitudinal measurements and event time data","volume":"1","author":"Henderson","year":"2000","journal-title":"Biostatistics (Oxford, England)"},{"key":"10.1016\/j.jcf.2018.12.005_bb0200","series-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"key":"10.1016\/j.jcf.2018.12.005_bb0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1099-0496(199910)28:4<231::AID-PPUL1>3.0.CO;2-2","article-title":"Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada","volume":"28","author":"Morgan","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2018.12.005_bb0210","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1541-0420.2010.01546.x","article-title":"Dynamic predictions and prospective accuracy in joint models for longitudinal and time-to-event data","volume":"67","author":"Rizopoulos","year":"2011","journal-title":"Biometrics"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318309433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318309433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:41:05Z","timestamp":1761601265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199318309433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1569199318309433"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2018.12.005","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of multiple event analysis as an alternative approach to studying pulmonary exacerbations as an outcome measure","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2018.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}